Recent Articles from Investor Brand Network

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising.

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising.

Coronary heart disease (“CHD”) remains the leading cause of death in the United States, but the tools doctors have long relied on to detect it early are proving less reliable than many patients assume. Cardio Diagnostics Holdings (NASDAQ: CDIO) reports that approximately 50% of individuals with coronary heart disease do not present with traditional risk factors and conventional risk calculators have an average sensitivity of 39%. In practical terms, that means that many who “look healthy” go on to have CHD and preventable cardiac events such as a heart attack.

The digital asset industry is entering a new phase of development. While early blockchain adoption was largely driven by speculation and asset appreciation, today’s market is increasingly focused on building sustainable financial infrastructure capable of supporting long-term institutional participation. Companies that can facilitate this transition are beginning to occupy an increasingly important role within the evolving digital asset ecosystem.

BioAdaptives (OTC: BDPT) announced that MyndRenew(TM), the nighttime component of its MyndSystem(TM) cognitive health platform, has received TruShield Certified status, confirming compliance with anti-doping standards established by the World Anti-Doping Agency and the UFC. Combined with the previously certified MyndMed(TM) daytime formula, the company said MyndSystem(TM) is now a fully WADA-compliant 24/7 cognitive performance and recovery system for professional athletes.

New research suggests that crypto use in the U.S . is increasingly shaped by political affiliation, while a far larger divide continues to exist between men and women.

Disseminated on behalf of Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) and may include paid advertising.

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising.

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising.

This article has been disseminated on behalf of Nicola Mining Inc. and may include paid advertising.

LIXTE Biotechnology (NASDAQ: LIXT) announced it has been added to the Russell Microcap(R) Index, effective after the close of U.S. markets on June 26, 2026, with the reconstituted index taking effect at the opening of trading on June 29, 2026. The company said inclusion in the widely followed benchmark is expected to increase its visibility among institutional investors and investment products that track Russell indexes.

Suntex Enterprises (OTC: SNTX) announced the completion of several strategic initiatives over the past two weeks, including fulfilling commitments under its asset purchase agreement with Golden Triangle Ventures, engaging a PCAOB-registered accounting firm to begin the audit process, appointing independent director Lisa Surnow and advancing plans to qualify for the OTCQB(R) Venture Market, subject to meeting applicable listing and regulatory requirements. The company also reported continued progress on its 100-acre mixed-use South Texas development and expansion of its commercial construction business through subsidiary JA Development & Construction.

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

Gold prices edged higher at the start of the week, supported by easing concerns in energy markets after early signs of progress emerged from discussions between the United States and Iran. This followed a tentative agreement to reopen the Strait of Hormuz, which helped calm fears of supply disruptions, while diplomatic efforts led by France saw President Trump endorse a framework aimed at reducing tensions and advancing negotiations.

Battery technology improvements and lower manufacturing costs have finally made it possible for European automakers to produce compact electric vehicles at affordable prices . These smaller models fit comfortably on the tight city streets of major European capitals, where larger vehicles struggle.

Alphabet experienced its steepest market setback since 2025 on June 22 as investor concerns surrounding artificial intelligence intensified following the resignation of two key researchers and growing questions about the company’s AI strategy.

According to recent data released by CMS actuaries, spending on health care in the U.S. jumped to $5.7tn in 2025, the third consecutive year in which spending growth exceeded 7%. The data shows that one of the key drivers of this spike was pricey medications, such as GLP-1s, medications used to treat obesity.

U.S. tech giant Anthropic has made shocking accusations against Alibaba, a Chinese technology and e-commerce company, of “illicitly” and “brazenly” extracting AI capabilities from Claude, Anthropic’s flagship AI model. The accusations were contained in a letter that the firm sent to Congress.

A new report from Aurora Energy Research finds that stronger European grid connections could unlock an extra 27TWh of clean power while reducing pollution via grid upgrades . The study, titled “Europe’s Energy Trilemma Rewired,” examines how grid investment could help address Europe’s three central energy priorities: cutting greenhouse gas emissions, securing energy supply chains, and managing costs.

Money in the crypto market often moves in patterns that can look dramatic at first glance. Recently, ETF flow data has created a strong narrative that money may be shifting from Bitcoin to XRP. But while there is some truth to this idea, the full picture is more balanced and less extreme than it sounds.

Safe Pro Group (NASDAQ: SPAI), a mission-driven tech company that develops AI-powered security and defense solutions, recently announced that it has rapidly delivered against a U.S. Army order for Threat Analysis Kits under an award valued at around $742,000 ( https://ibn.fm/smCGt ).

This article has been disseminated on behalf of ComprehensiveHealthcare Systems Inc. and may include paid advertising.

This article has been disseminated on behalf of ComprehensiveHealthcare Systems Inc. and may include paid advertising.

Datavault AI (NASDAQ: DVLT) announced a partnership with 21 In Right Inc., the Clemente family entity that manages the name, image and likeness of Baseball Hall of Famer Roberto Clemente, to apply its data valuation, monetization and digital Twin technologies to preserve and expand Clemente’s legacy. Under the agreement, 21 In Right will use Datavault AI’s platforms to manage and protect Clemente’s NIL rights, create digital Twins and archives, and develop new fan engagement initiatives in collaboration with the Roberto Clemente Foundation and other aligned organizations.

Wrap Technologies (NASDAQ: WRAP) is an innovator of modern policing solutions. The company’s BolaWrap(R) product is a patented, hand-held remote restraint device that discharges an eight-foot bola style Kevlar(R) tether to restrain an individual at a range of 10-25 feet. Developed by award-winning inventor Elwood Norris, the company’s chief technology officer, the small-but-powerful BolaWrap assists law enforcement in safely and effectively controlling encounters, especially those involving an individual experiencing a mental crisis.

Exploring the policies, markets and global events influencing currencies and the movement of money worldwide

This article has been disseminated on behalf of Energy F u els Inc. and may include paid advertising.

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) (FSE: P6U) and may include paid advertising.

Versus Systems (NASDAQ: VS) developed and operates a patented earned-rewards platform that enables brands, sports teams, broadcasters and content creators to embed games and real-world prizes directly into digital and live experiences. A recent article discussing this reads, “The platform encourages participation through interactive challenges, contests and reward-based activities… Versus has engaged more than 10 million consumers through campaigns deployed across sports, entertainment and corporate environments. The company’s technology has been used alongside major brands, sports franchises and media organizations, demonstrating how gamification is increasingly becoming part of broader marketing strategies.”

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising.

TechForce Robotics, Inc. (“TechForce”), a subsidiary of Nightfood Holdings, Inc. (OTCQB: NGTF), is extending the boundaries of service robotics commercialization, moving its AI-powered automation platforms from pilot deployments into industrial-scale, revenue-generating fleet systems. Reputed for developing autonomous service robots created for logistics, hospitality, healthcare, and commercial settings, the company is now advancing toward full-scale commercialization through integrated manufacturing and deployment partnerships, opening the door to a new era of scalable Robotics-as-a-Service Provider (“RaaSP”) adoption across enterprise markets ( ibn.fm/KnktY ).

This article has been disseminated on behalf of Helus Pharma and may include paid advertising.

Bitcoin climbed back above the $65,000 mark on Monday, June 22, as easing geopolitical tensions in the Middle East and declining oil prices improved investor confidence across global markets.

The failure of the U.S. Congress to extend the public subsidies that were helping millions of Americans to access public health insurance has resulted in millions losing their health coverage, deepened inequality and increased financial hardship for the most affected, according to Oxfam America and Human Rights Watch.

Uruguay has fundamentally reshaped its energy future as a global energy crisis rages on. Today, nearly all electricity powering this nation comes from wind, solar, hydropower, and biomass, a dramatic shift from two decades ago when energy crises plagued the country. The transformation has delivered measurable benefits across the economy, and international observers are studying how Uruguay engineered this change so effectively.

The European Union is reportedly considering new tariffs on plug-in hybrid electric vehicles (PHEVs) imported from China. The move comes as European officials continue to examine the growing presence of Chinese automakers in the region and the impact their vehicles may have on local manufacturers.

The medical community has for long relied on antibiotic prophylaxis, the practice of prescribing antibiotics to safeguard at-risk individuals from bacterial infections. However, a new publication has sounded the alarm on the widespread use of these “just in case” treatments due to their risk of driving antibiotic resistance.

The United States’ clean energy transition is facing new challenges as policy priorities increasingly favor fossil fuels over renewable energy. One of the most visible examples is the renaming of the National Renewable Energy Laboratory, a globally recognized center for renewable energy research.

Researchers at the Massachusetts Institute of Technology have weighed in on a long-running debate over whether battery-powered cars truly pollute less than gasoline vehicles . Skeptics often point to the resources needed to mine EV battery materials, while supporters argue that avoiding tailpipe emissions makes electric cars cleaner overall.

Just days after its public debut, Anthropic’s most advanced AI system was removed from circulation following intervention by the Trump administration, which cited national security concerns tied to a reported security bypass.

Nightfood Holdings (OTCQB: NGTF) doing business as TechForce Robotics, announced it has signed a non-binding letter of intent to acquire a 51% controlling interest in Taiwan-based Jiun Jiang Enterprise Co. Ltd., a manufacturer of semiconductor automation, advanced packaging equipment, robotics and intelligent manufacturing systems. The proposed all-stock transaction would make JJ Enterprise a majority-owned operating subsidiary, with the purchase price tied to audited financial performance under U.S. GAAP and subject to due diligence, definitive agreements and other closing conditions.

American Fusion (OTC: AMFN) announced it has finalized the comprehensive testing protocol for its 5MW Pre-Production Texatron(TM) Fusion Engine(TM), establishing the engineering and scientific framework that will guide validation of the company’s fusion energy platform. The protocol includes plasma density and temperature measurements, neutron monitoring, spectroscopy, electrical power analysis and calibration procedures, while also providing for independent scientific observation, public release of testing video and third-party evaluation of results as the company advances toward commercial validation.

Earth Science Tech (OTC: ETST), a strategic holding company that acquires and manages a diverse portfolio of businesses, recently announced the financial results for the full fiscal year that ended on March 31, 2026 ( https://ibn.fm/xRoIz ).

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising.

HeartBeam (NASDAQ: BEAT) announced a strategic reorganization aimed at accelerating execution, expanding global market reach and improving capital efficiency as it advances commercialization of its cardiac monitoring technology. Under the new structure, Founder and President Branislav Vajdic, Ph.D., and Executive Chairman Rich Ferrari will lead focused implementation teams designed to streamline decision-making, improve accountability and reduce costs. As part of the transition, former CEO Robert Eno will move into a consulting role.

Greenland Mines (NASDAQ: GRML) announced it has completed a three-day, multidisciplinary planning workshop for its Skaergaard Precious and Critical Metals Project in southeast Greenland, bringing together more than 15 international experts from GTK Mintec, the Geological Survey of Finland, SLR Consulting, WSP Denmark and other technical specialists. The June 22-24 sessions focused on advancing understanding of the orebody and processing pathways, planning 2026 drilling, sampling and environmental programs and establishing a roadmap toward an Initial Assessment (“IA”) or Preliminary Economic Assessment (“PEA”) and future development.

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.

Versus Systems (NASDAQ: VS), a leading provider of gamification and audience engagement technology, has received new attention from the investment community following the initiation of research coverage by Zacks Investment Research, which highlighted the company’s recent operational progress and future growth opportunities ( https://nnw.fm/VDBzc ).

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising.

MindWave Innovations (NYSE American: APUS) is positioning as bitcoin moves deeper into corporate finance and many companies contemplate not whether digital assets belong on the balance sheet but rather how they can be held, reported and deployed responsibly. “MindWave provides a secure and compliant gateway to digital assets through insured custody solutions, AI-enabled yield strategies and transparent reporting systems. That combination is important because corporate adoption depends not only on asset exposure but also on the ability to demonstrate that treasury activity is documented and aligned with the expectations of directors, auditors and shareholders,” reads a recent article.

Oncotelic Therapeutics (OTCQB: OTLC) was featured in a recent article that discussed the company’s efforts to move beyond its roots as a clinical-stage biotechnology company into the quickly expanding intersection of artificial intelligence and industrial automation. The publication reads, “Through two closely aligned announcements, the firm has unveiled a strategic partnership with TechForce Robotics, which positions it to commercialize a next-generation, AI-enhanced platform created for regulated pharmaceutical environments… At the core of this pivot is Oncotelic’s proprietary PDAOAI platform, an AI-driven system designed to improve compliance, monitoring, and operational intelligence. By integrating this innovation with TechForce Robotics’ hardware and manufacturing expertise, the companies aim to deliver a GMP-compliant robotics solution capable of automating critical workflows in pharmaceutical production and laboratory settings.”

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, has announced new in vitro proof-of-concept data supporting its BiTAC-ADC platform, a technology designed to improve the selectivity of antibody-drug conjugates in cancer treatment. The announcement comes as the company prepares to engage with potential pharmaceutical and biotechnology partners during the BIO International Convention 2026 in San Diego ( https://nnw.fm/APy2D ).

Energy, Oil & Gas Magazine profiles CEO Robert Price as company prepares for October 2026 exploration campaign in East Greenland

Artificial intelligence has become a part of everyday life for millions of people. Tools such as ChatGPT, Claude, and other AI assistants are now used for learning, work, research, and finding information online. While these technologies offer many benefits, a new study suggests that relying too much on AI may have negative effects on critical thinking and independent judgment.

Researchers from King’s College London and McMaster University have made a discovery that could fundamentally change how doctors treat brain cancer. The team identified a molecular pathway that appears critical to cancer’s ability to migrate to the brain.

On Monday, precious metal prices ticked upwards. Gold reached $4,362 an ounce, marking gains of approximately 3.4%. Silver’s price hit $71.2 an ounce, a rally of about 4.7%. We look at some of the key factors that are driving this rally in precious metal prices as this week progresses.

BioMedWire Editorial Coverage: Oncology research is moving through one of its most active stretches in years. DNA Damage Response (“DDR”) inhibitors, a category of drugs that work by blocking cancer cells’ capacity to fix their own damaged DNA, are growing well beyond the poly ADP ribose polymerase (“PARP”) inhibitor that first defined the category. DDR-inhibiting therapies generated an estimated $7 billion-plus in worldwide sales in 2025, and the wider oncology, diagnostics and precision medicine markets are expected to approach about $750 billion by 2030. A fresh wave of inhibitor classes is now taking shape as the next major opportunity. Standing at the leading edge of this shift is Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) ( Profile ), a Canadian clinical-stage oncology company developing ONC010(TM), a nanoparticle-encapsulated PNKP inhibitor designed to target a DNA repair enzyme that participates in several distinct repair pathways. As the industry works toward the next generation of synthetic lethality assets, Onco-Innovations occupies a distinctive niche as it builds out its position within the biopharmaceutical and biotechnology space, alongside other established companies such as Merck & Co. Inc. (NYSE: MRK), Pfizer Inc. (NYSE: PFE), GSK plc (NYSE: GSK) and Gilead Sciences Inc. (NASDAQ: GILD), all of which are focused on…

BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) gradually strips people of command over their own bodies, advancing steadily with no available cure. More than 2.9 million people across the globe are currently living with the disease. But even with generations of scientific study and research, every approved treatment still falls short of one essential objective: bringing the disease to a complete stop. Existing therapies can slow its advance, but none can halt it outright. That shortfall translates into a future of mounting disability for millions of MS sufferers. Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) ( Profile ) is determined working to change that outcome. The company is developing Lucid-MS, a patented, first-in-class drug candidate that approaches the disease from an entirely different angle by directly targeting the myelin sheath that MS destroys; the potential treatment is now preparing to move into phase 2 clinical trials. Quantum BioPharma stands among a group of companies pursuing therapies for neurological, autoimmune and immune-mediated conditions, a group that also includes Novartis AG (NYSE: NVS), Merck & Co. Inc. (NYSE: MRK), TG Therapeutics Inc. (NASDAQ: TGTX) and…

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform offering a quicker and easier path to home ownership, was added as a member of the Russell Microcap Index, marking a notable milestone for the digital mortgage company as it attempts to scale its technology-driven lending platform during one of the most challenging housing finance environments in years.

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising.

Cardio Diagnostics Holdings (NASDAQ: CDIO), an AI-powered precision cardiovascular medicine company, announced that Atlas Healthcare Physicians, an independent physician association serving managed care populations across Los Angeles and Orange counties, will provide coverage for the company’s Epi+Gen CHD(TM) and PrecisionCHD(TM) tests for eligible members with prior authorization. The coverage expands access to physician-ordered blood tests designed to assess coronary heart disease risk and support diagnosis and personalized treatment planning.

Massimo Group (NASDAQ: MAMO), a manufacturer and distributor of powersports vehicles and mobility solutions, announced it has terminated its previously proposed acquisition of FST Development Company Limited. The company said that after reviewing its strategic priorities, capital allocation plans and recent development progress, it elected not to proceed with the transaction or the previously contemplated stock-based acquisition structure.

Gaxos.ai (NASDAQ: GXAI) a developer of artificial intelligence applications across multiple industries, announced the completion of the sale of its gaming assets, including its portfolio of mobile games and Gaxos Gaming Labs, to privately held Game Foundry AI. The all-stock transaction was valued at approximately $1.76 million and is intended to support Gaxos’ strategy of focusing resources on its revenue-generating AI businesses and higher-margin commercial opportunities.

Rail Vision (NASDAQ: RVSN) (FSE: C80), a developer of AI-powered railway safety and sensing systems, announced the successful completion of ShuntingYard field testing with Israel Railways. The evaluation was conducted during daily rail yard operations, where locomotive drivers and operational personnel assessed the system’s ability to detect and classify potential obstacles in real time under active and challenging operating conditions. According to the company, feedback from Israel Railways personnel was positive, highlighting the system’s ability to enhance situational awareness during shunting activities.

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising.

This article has been disseminated on behalf of Helus Pharma and may include paid advertising.

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.

This article has been disseminated on behalf of Helus Pharma and may include paid advertising.

Greenland Mines (NASDAQ: GRML) is focused on the exploration and development of mineral assets in Greenland. Through its mining division, the company is advancing the Skaergaard Project in southeast Greenland while also pursuing the acquisition of the Sarfartoq rare earth project in southwest Greenland. Together, these assets provide exposure to precious metals, critical metals and rare earth elements within a jurisdiction that has attracted growing interest as governments and industries seek to diversify strategic mineral supply chains.

VERAXA Biotech (NASDAQ: VRXA) an emerging developer of novel cancer therapies, announced it has expanded its laboratory footprint at its existing research and development site in Heidelberg, Germany, under a previously executed long-term lease agreement. The additional space will support planned growth of the company’s R&D team, installation of new laboratory equipment and completion of infrastructure needed to advance future development activities.